Tipsheet
What matters at India’s listed companies
Earnings · Chemicals · Large cap

Himadri Speciality's Q1 transcript adds no new facts

Record revenue of ₹1,432 crore and PAT of ₹228 crore were already disclosed. The transcript recaps a live call; no fresh data emerges.

3 earlier stories on Himadri Speciality Chemical Ltd.
Mkt cap₹34,213 cr
P/E45.54×
ROE15.96%
Debt / eq.0.16
Div yld0.12%
₹1,432 cr Record Q1 revenue — already reported on July 15.

What's new

  • Transcript of July 16 earnings call released to exchanges.
  • Contains no financial or operational data beyond prior disclosures.
  • Management discussion on capex and battery materials already known.

Why this matters

Transcripts are backward-looking documentation of live calls; they carry no standalone investment significance. For Himadri, the record Q1 numbers and capex plans were already priced in. This filing is a routine procedural step.

What we're watching

  • Execution of the ₹2,000 crore battery materials capex over two years.
  • Updates on the carbon nanotube facility and super speciality carbon black expansion.
  • Progress on Birla Tyres and any signs of sustained margin improvement.

The full read

Himadri Speciality Chemical released the transcript of its Q1 FY27 earnings call, a formality rather than news. The record revenue of ₹1,432 crore and PAT of ₹228 crore were already out on July 15-16, alongside a ₹2,000 crore battery-materials capex plan and ₹368 crore in project approvals. The transcript recaps live discussion and Q&A; no fresh price-sensitive data emerges. For an investor who followed the initial release, this filing offers nothing actionable. The open questions remain execution of the capex pipeline and margin sustainability, neither of which the transcript advances.

Questions answered

Does the transcript contain any new price-sensitive information?
No. All material financials (record revenue and profit) and major capex plans were announced in the earnings release on July 15-16. The transcript merely recaps the subsequent Q&A.
What did management say about the carbon nanotube facility?
Management discussed it as a new capex initiative, but no new capacity or capex figures were revealed beyond the ₹2,000 crore battery materials programme previously announced.
Is the transcript useful for investors?
Not for new information, but analysts may mine it for nuanced commentary on demand, pricing, or execution timelines that weren't in the initial earnings release.
What is the company's current capex plan?
Himadri has announced a two-year, ₹2,000 crore self-funded capex for battery materials, plus ₹368 crore approved for three specific projects as of July 15.
How does the record Q1 performance compare with prior quarters?
Revenue of ₹1,432 crore and PAT of ₹228 crore are all-time highs. Trailing ROE stands at 16%, with a debt/equity of 0.16.
Mentioned: ₹1,432 cr record revenue · ₹2,000 cr battery materials capex · Q1 FY27
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Himadri Speciality Chemical Ltd.

Chemicals
₹39,825 cr
P/E 49.83×

Latest quarter · Jun 2026

Sales₹1,432 cr
Net profit₹228 cr
Op. margin+20.1%
EPS₹4.55

Strength & growth

Debt / equity0.16×
Current ratio2.09×
Sales CAGR+15.4%
EPS CAGR+46.1%
Financials via Tijori — a research aid, not investment advice.HSCL on Tijori

Story so far

All notes on HSCL →
  1. 21 Jul 2026 · 7:32 PM IST Himadri Speciality's Q1 transcript adds no new facts
  2. 12d ago Himadri Speciality targets ₹2,000 cr battery materials spend
  3. 13d ago Himadri Speciality notches record Q1 revenue, margins at 22%
  4. 13d ago Himadri Speciality Chemical posts 28% revenue growth, approves ₹368 cr capex